- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 460706, 18 pages
Natural Killer Dendritic Cells Enhance Immune Responses Elicited by α-Galactosylceramide-Stimulated Natural Killer T Cells
1Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, Seoul 143-747, Republic of Korea
2Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea
Received 31 December 2012; Revised 28 April 2013; Accepted 13 May 2013
Academic Editor: Anton M. Jetten
Copyright © 2013 Sung Won Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier, “Natural-killer cells and dendritic cells: “l'union fait la force”,” Blood, vol. 106, no. 7, pp. 2252–2258, 2005.
- D. I. Godfrey, K. J. L. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter, “NKT cells: facts, functions and fallacies,” Immunology Today, vol. 21, no. 11, pp. 573–583, 2000.
- C. Carnaud, D. Lee, O. Donnars et al., “Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells,” Journal of Immunology, vol. 163, no. 9, pp. 4647–4650, 1999.
- S.-I. Fujii, K. Shimizu, H. Hemmi, and R. M. Steinman, “Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity,” Immunological Reviews, vol. 220, no. 1, pp. 183–198, 2007.
- Y. Ueda, M. Hagihara, B. Gansuvd, et al., “The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord blood,” Cancer Immunology, Immunotherapy, vol. 52, no. 58, pp. 625–631, 2003.
- J. Hua, S. Liang, X. Ma, T. J. Webb, J. P. Potter, and Z. Li, “The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity,” PLoS ONE, vol. 6, no. 11, article e27038, 2011.
- D. Hongo, X. Tang, S. Dutt, R. G. Nador, and S. Strober, “Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants,” Blood, vol. 119, no. 6, pp. 1581–1589, 2012.
- K. H. Oh, C. Lee, S. W. Lee et al., “Activation of natural killer T cells inhibits the development of induced regulatory T cells via IFNγ,” Biochemical and Biophysical Research Communications, vol. 411, no. 3, pp. 599–606, 2011.
- S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008.
- P. Trzonkowski, E. Szmit, J. Myśliwska, A. Dobyszuk, and A. Myśliwski, “CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction,” Clinical Immunology, vol. 112, no. 3, pp. 258–267, 2004.
- N. Ralainirina, A. Poli, T. Michel et al., “Control of NK cell functions by CD4+CD25+ regulatory T cells,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 144–153, 2007.
- U. K. Liyanage, T. T. Moore, H.-G. Joo et al., “Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma,” Journal of Immunology, vol. 169, no. 5, pp. 2756–2761, 2002.
- V. G. Pillarisetty, S. C. Katz, J. I. Bleier, A. B. Shah, and R. P. DeMatteo, “Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL-12,” Journal of Immunology, vol. 174, no. 5, pp. 2612–2618, 2005.
- C. W. Chan, E. Crafton, H.-N. Fan et al., “Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity,” Nature Medicine, vol. 12, no. 2, pp. 207–213, 2006.
- J. Taieb, N. Chaput, C. Ménard et al., “A novel dendritic cell subset involved in tumor immunosurveillance,” Nature Medicine, vol. 12, no. 2, pp. 214–219, 2006.
- N. Larmonier, J. Fraszczak, D. Lakomy, B. Bonnotte, and E. Katsanis, “Killer dendritic cells and their potential for cancer immunotherapy,” Cancer Immunology, Immunotherapy, vol. 59, no. 1, pp. 1–11, 2010.
- U. I. Chaudhry, S. C. Katz, T. P. Kingham et al., “In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells,” The FASEB Journal, vol. 20, no. 7, pp. 982–984, 2006.
- H. Lecoeur, M. Février, S. Garcia, Y. Rivière, and M.-L. Gougeon, “A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity,” Journal of Immunological Methods, vol. 253, no. 1-2, pp. 177–187, 2001.
- K. Hochweller, J. Striegler, G. J. Hämmerling, and N. Garbi, “A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells,” European Journal of Immunology, vol. 38, no. 10, pp. 2776–2783, 2008.
- E. Assarsson, T. Kambayashi, J. D. Schatzle et al., “NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions,” Journal of Immunology, vol. 173, no. 1, pp. 174–180, 2004.
- B. Messmer, P. Eissmann, S. Stark, and G. Watzl, “CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells,” Journal of Immunology, vol. 176, no. 8, pp. 4646–4650, 2006.
- G. Trinchieri, “Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity,” Annual Review of Immunology, vol. 13, pp. 251–276, 1995.
- D. Caretto, S. D. Katzman, A. V. Villarino, E. Gallo, and A. K. Abbas, “Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells,” Journal of Immunology, vol. 184, no. 1, pp. 30–34, 2010.
- J.-H. Chang, Y.-J. Kim, S.-H. Han, and C.-Y. Kang, “IFN-γ-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis,” European Journal of Immunology, vol. 39, no. 5, pp. 1241–1251, 2009.
- X. Valencia, G. Stephens, R. Goldbach-Mansky, M. Wilson, E. M. Shevach, and P. E. Lipsky, “TNF downmodulates the function of human CD4+CD25hi T-regulatory cells,” Blood, vol. 108, no. 1, pp. 253–261, 2006.
- M. Jinushi, T. Takehara, T. Tatsumi et al., “Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid,” International Journal of Cancer, vol. 104, no. 3, pp. 354–361, 2003.
- D. Wågsäter, J. Dimberg, A. Hugander, A. Sirsjö, and M. Ghaderi, “Analysis of MICA gene transcripts in human rectal cancers,” Anticancer Research, vol. 23, no. 3 B, pp. 2525–2529, 2003.
- S.-M. Lu, P. Xiao, L. Xue et al., “Prevalent expression of MHC class I chain-related molecule A in human osteosarcoma,” Neoplasma, vol. 55, no. 3, pp. 266–272, 2008.
- T. A. Moo-Young, J. W. Larson, B. A. Belt et al., “Tumor-derived TGF-β mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer,” Journal of Immunotherapy, vol. 32, no. 1, pp. 12–21, 2009.
- S. Roux, L. Apetoh, F. Chalmin et al., “CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer,” Journal of Clinical Investigation, vol. 118, no. 11, pp. 3751–3761, 2008.
- D. Hackl, J. Loschko, T. Sparwasser, W. Reindl, and A. B. Krug, “Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs,” European Journal of Immunology, vol. 41, no. 5, pp. 1334–1343, 2011.
- F. S. Wong and C. M. Dayan, “Regulatory T cells in autoimmune endocrine diseases,” Trends in Endocrinology and Metabolism, vol. 19, no. 8, pp. 292–299, 2008.
- G. Liao, S. Nayak, J. R. Regueiro et al., “GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells,” International Immunology, vol. 22, no. 4, pp. 259–270, 2010.
- L. T. Krausz, E. Fischer-Fodor, Z. Z. Major, and B. Fetica, “GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 190, pp. 59–66, 2012.
- G. Darrasse-Jèze, S. Deroubaix, H. Mouquet et al., “Feedback control of regulatory T cell homeostasis by dendritic cells in vivo,” Journal of Experimental Medicine, vol. 206, no. 9, pp. 1853–1862, 2009.
- S. Caielli, C. Conforti-Andreoni, C. Di Pietro et al., “On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1D-mediated interaction with invariant NKT cells,” Journal of Immunology, vol. 185, no. 12, pp. 7317–7329, 2010.
- C. Paget, M. T. Chow, H. Duret, S. R. Mattarollo, and M. J. Smyth, “Role of γδ T cells in α-galactosylceramide-mediated immunity,” Journal of Immunology, vol. 188, no. 8, pp. 3928–3939, 2012.